CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-24 | Tactic Pharma LLC 10% owner | Sale | −550,229 | $63.61 | $35.0M | 272,026 |
| 2025-04-02 | Tactic Pharma LLC 10% owner | Sale | −33,334 | $35.00 | $1.2M | 822,255 |
| 2021-02-11 | Tactic Pharma LLC 10% owner | Sale | −42,467 | $13.30 | $565K | 249,200 |
| 2021-02-11 | Tactic Pharma LLC 10% owner | Sale | −24,224 | $14.09 | $341K | 224,976 |
| 2021-02-11 | Tactic Pharma LLC 10% owner | Sale | −29,996 | $15.12 | $454K | 194,980 |
| 2021-02-11 | Tactic Pharma LLC 10% owner | Sale | −16,384 | $16.44 | $269K | 178,596 |
| 2021-02-11 | Tactic Pharma LLC 10% owner | Sale | −11,929 | $16.90 | $202K | 166,667 |
| 2019-12-18 | Tactic Pharma LLC 10% owner | Purchase | +125,000 | $8.00 | $1.0M | 291,667 |
Page 1 of 1 · 8 trades